NCT02643017

Brief Summary

Investigate the effects of dexmedetomidine on postoperative cognitive function in patients undergoing shoulder arthroscopy with beach chair position under desflurane anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 11, 2015

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

December 15, 2015

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 30, 2015

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 16, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 16, 2018

Completed
Last Updated

January 25, 2019

Status Verified

January 1, 2019

Enrollment Period

2.7 years

First QC Date

December 15, 2015

Last Update Submit

January 23, 2019

Conditions

Keywords

cognitive functiondesfluranedexmedetomidine

Outcome Measures

Primary Outcomes (2)

  • Number of patients with postoperative cognitive decline assessed by mini-mental state examination

    to compare cognitive decline after surgery between control and dexmedetomidine group with mini-mental state examination.

    from 1 day before surgery to postoperative 1 day

  • Number of patients with postoperative cognitive decline assessed by a battery of psychometric test

    to compare cognitive decline after surgery between control and dexmedetomidine group with a battery of psychometric test. The battery consists of copy geometric form test, two-dimensional model test, grooved pegboard test, colored block design test, puzzle test, clock drawing test.

    from 1 day before surgery to postoperative 1 day

Secondary Outcomes (1)

  • Number of patients with increase of S100ß protein after surgery assessed by ELISA assay with blood of patients

    from 5 min after induction of anesthesia to an 1 hour after surgery

Study Arms (2)

normal saline

PLACEBO COMPARATOR
Drug: normal saline

Dex

EXPERIMENTAL
Drug: Dexmedetomidine

Interventions

Administration of dexmedetomidine at a rate 0.6 ug/kg/hr during surgery.

Dex

Administration of same amount of dexmedetomidine at a rate 0.6 ug/kg/hr during surgery.

normal saline

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Patients undergoing shoulder arthroscopic surgery with beach chair position

You may not qualify if:

  • Patients with respiratory disease
  • Patients with cardiac disease
  • Patients with cerebrovascular disease
  • patients with uncontrolled hypertension
  • Patients with dementia
  • Patients with psychiatric disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University College of Medicine

Seoul, 03722, South Korea

Location

MeSH Terms

Conditions

Rotator Cuff Injuries

Interventions

DexmedetomidineSaline Solution

Condition Hierarchy (Ancestors)

RuptureWounds and InjuriesShoulder InjuriesTendon Injuries

Intervention Hierarchy (Ancestors)

ImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2015

First Posted

December 30, 2015

Study Start

December 11, 2015

Primary Completion

August 16, 2018

Study Completion

August 16, 2018

Last Updated

January 25, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

There is no plan to share the data.

Locations